Ottawa, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The global clinical trials support software solutions market size is calculated at USD 14.31 billion in 2026 and is expected to reach around USD 34.15 billion ...

The "Clinical Trial Management Systems (CTMS) - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Clinical Trial Management Systems (CTMS) is ...

Investigator-initiated trials are uniquely unsuited to a patchwork of Google Drive folders, Excel worksheets, and consumer-grade software. Industry sponsors deploy full ...

Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsors "We need to work efficiently to help more families enroll their children in studies and get lifesaving ...

Jeeva Clinical Trials, a leader in decentralized clinical trials technology announces the launch of its CRO Partnership Program to streamline & automate trials. Rare disease trials are already complex ...

ORLANDO, Fla. , Feb. 3, 2025 /PRNewswire/ -- SCOPE 2025 – Oracle Life Sciences has been named a 'Leader' in the Everest Group Life Sciences Clinical Trial Management System (CTMS) Products PEAK ...

PLEASANTON, Calif. , Oct. 17, 2022 /PRNewswire/ -- Veeva Systems (VEEV) (NYSE: VEEV) today announced that 40 contract research organizations (CROs) selected Veeva Vault CTMS to deliver faster and more ...

Forbes contributors publish independent expert analyses and insights. Podcast and video host & producer, journalist and speaker/moderator. Every year, thousands of life-saving clinical trials are ...

Veeva Systems Inc. VEEV recently announced that with the growing need for greater efficiency in clinical studies, more than 100 organizations are simplifying trial management and monitoring via the ...

Morning Hubsters, John R Fischer here in the New York newsroom coming at you with the US Wire. Surgical procedures are on the rise – several sources estimate over 300 million are performed each year ...

How much do clinical trials cost? The most-quoted numbers are arguably that each trial individually costs a median of $19M, each trial for an eventually-approved drug costs a median of about $48M, and ...